Two novel peptides derived from Protagonist's proprietary discovery platform are currently in advanced Phase 3 clinical development, with New Drug Application submissions to the FDA potentially in ...

The proposal was delivered in writing by Iranian Foreign Minister Abbas Araghchi to U.S. Special Envoy Steve Witkoff during three hours of talks on Saturday, reported Iran International. In the first ...

NEW YORK--(BUSINESS WIRE)--Mind Medicine (MindMed ... today announced that the first patient has been dosed in its Phase 3 Emerge study evaluating MM120 ODT, a proprietary, pharmaceutically ...